Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4171 to 4185 of 9008 results

  1. Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain (HTG641)

    Evidence-based recommendations on neurostimulation of lumbar muscles for refractory non-specific chronic low back pain in adults. This involves implanting a pulse generator under the skin of the upper buttock or lower back, which the person can use to manage their pain.

    HealthTech guidance
    Published
    22 September 2022
    View recommendations

    Sections for HTG641

  2. Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver (HTG575)

    Evidence-based recommendations on melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver. This involves diverting the blood flow from the liver to the rest of the body while the drug is delivered directly into the liver.

    HealthTech guidance
    Published
    21 April 2021
    View recommendations

    Sections for HTG575

  3. Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (HTG572)

    Evidence-based recommendations on transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids in adults. This involves inserting a device through the cervix into the womb to destroy the fibroid using radiofrequency energy.

    HealthTech guidance
    Published
    31 March 2021
    View recommendations

    Sections for HTG572

  4. Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI (HTG515)

    Evidence-based recommendations on percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI in adults. This involves placing a device inside an artery near the heart.

    HealthTech guidance
    Published
    12 June 2019
    View recommendations

    Sections for HTG515

  5. Into practice resources

    Resources, case studies and patient decision aids to show how you can use evidence to improve care and services

  6. Contributing to the development of our guidance

    We've created the guides and resources on this page to help people who are involved in developing NICE guidelines.

  7. Payments and expenses

    Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.

  8. Medical technologies advisory committee members

    Read the biographies of our medical technologies advisory committee members.

  9. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    Page 1 of 11 Taking tamoxifen to reduce the chance of developing breast cancer Decision aid for premenopausal women at high risk Published

  10. NICE and virtual wards

    We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.

  11. Diagnostics advisory committee members

    Biographies for all current members of the diagnostics advisory committee.

  12. Topic prioritisation

    Find out what guidance is being considered for development

  13. Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template (PMG24)

    This is the user guide for submission of evidence to the National Institute for Health and Care Excellence (NICE) as part of the single technology appraisal and highly specialised technologies evaluations process. It explains what information NICE requires and the format in which it should be presented

  14. Appeal panel membership

    The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.

  15. Medicines associated with dependence or withdrawal symptoms. Patient decision aid summary version on should I stop my benzodiazepine or z-drug?

    Should I stop my benzodiazepine or z-drug? Patient decision aid: summary Do not stop taking your benzodiazepine or z-drug suddenly What are...